Business Context and Reporting Period
Company: Cardinal Health, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: June 30, 1996
Business Overview: Cardinal Health is a leading health care service provider and one of the largest wholesale distributors of pharmaceutical and related health care products in the United States. The company operates through several key segments: pharmaceutical distribution, automated point-of-use systems (Pyxis Corporation), pharmacy management services (Allied Pharmacy Service), and retail pharmacy franchising (Medicine Shoppe International). The company serves hospitals, independent and chain drugstores, and mass merchandisers.
Key Financial Metrics
| Metric | Fiscal 1996 | Fiscal 1995 |
|---|---|---|
| Net Revenues | $8,862,425,000 | $8,022,108,000 |
| Gross Margin | $715,277,000 (8.07%) | $624,551,000 (7.79%) |
| Operating Earnings | $214,772,000 | $245,972,000 |
| Net Earnings (Common Shares) | $111,864,000 | $137,534,000 |
| Earnings Per Share (Diluted) | $1.73 | $2.14 |
| Total Assets | $2,681,095,000 | $2,160,961,000 |
| Long-Term Obligations | $265,144,000 | $209,214,000 |
| Working Capital | $854,120,000 | $765,683,000 |
| Cash and Equivalents | $287,802,000 | $64,589,000 |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 10.5% to $8.86 billion, driven by internal growth in pharmaceutical wholesaling, new customer additions, and price increases.
- Profitability Decline: Net earnings decreased 18.6% to $111.9 million. This decline was primarily due to unusual items totaling $67.3 million ($47.8 million net of tax) associated with the mergers of Medicine Shoppe and Pyxis. These costs included transaction fees, restructuring, and employee retention expenses.
- Margin Expansion: Gross margin percentage improved to 8.07% from 7.79%, attributed to the higher-margin pharmacy management operations acquired in fiscal 1996.
- Liquidity Improvement: Working capital increased by $88.4 million. Cash and equivalents rose significantly by $223.2 million, supported by a $150 million public offering of 6% Notes due 2006 in January 1996.
- Debt Structure: Long-term obligations increased due to the new $150 million note issuance and the current portion of $100 million in 8% Notes due in March 1997.
Guidance, Outlook, and Risks
- Acquisition Strategy: The company continues to pursue acquisitions to diversify into higher-margin health care services. On July 24, 1996, it announced a definitive merger agreement with PCI Services, Inc., a packaging services provider, expected to close in fall 1996.
- Customer Concentration Risk: Kmart Corporation accounted for approximately 12% of net revenues in fiscal 1996. The loss of this customer could adversely affect the business.
- Supplier Concentration: The five largest suppliers accounted for 22.5% of net revenues. Relationships are generally good, but contracts can often be canceled with 30 to 90 days' notice.
- Legal Proceedings: The company is a defendant in consolidated antitrust litigation regarding chargeback pricing systems. Summary judgment was granted in the company's favor in April 1996, though plaintiffs have appealed. Management does not believe the outcome will have a material adverse effect.
- Accounting Standards: The company is evaluating the impact of SFAS No. 123 (Stock-Based Compensation) and SFAS No. 121 (Impairment of Long-Lived Assets), required for adoption in fiscal 1997.
Investor Verification Checklist
- Unusual Items Impact: Verify the sustainability of earnings by excluding the $67.3 million in merger-related costs. Adjusted operating earnings were $282.0 million, and adjusted EPS was $2.47.
- Merger Integration: Assess the integration progress and cost synergies of the Medicine Shoppe and Pyxis acquisitions completed in fiscal 1996.
- PCI Merger Status: Monitor the completion of the pending PCI Services merger and the associated one-time transaction charges expected in the next fiscal period.
- Debt Maturity: Confirm the refinancing or repayment plan for the $100 million in 8% Notes due in March 1997.
- Customer Retention: Evaluate the stability of the relationship with Kmart, given its 12% revenue contribution.